You are here: Industry Insights > Stem cell therapy

News List

Experimental stem cell therapy trial for COVID-19 initiated europeanpharmaceuticalreview
May 29, 2020
Researchers announce the first patient has been dosed in a trial testing remestemcel-L, a stem cell therapy, in severe COVID-19 patients on ventilators.
Hope Biosciences gets FDA nod for phase 2 COVID-19 stem cell therapy trial pharmaceutical-business-review
April 16, 2020
Hope Biosciences has been given clearance from the US Food and Drug Administration (FDA) to move ahead with a phase 2 trial to evaluate its investigational stem cell therapy in providing immune support against COVID-19.
US researchers to study stem cell therapy in COVID-19 patients europeanpharmaceuticalreview
April 15, 2020
The FDA has approved a clinical trial to study COVID-19 patients administered with umbilical cord-derived mesenchymal stem cells, which should prevent lung inflmammation.
Seneca Completes Stem Cell Manufacturing Facility contractpharma
April 14, 2020
Seneca Biopharma, a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, has completed its new cell manufacturing facility in Suzhou, China.
Stem cell therapy shows efficacy at treating COVID-19, finds study europeanpharmaceuticalreview
April 01, 2020
Researchers in China administered COVID-19 patients with a mesenchymal stem cell therapy that demonstrated success at treating the condition.
EU clears first allogeneic stem cell therapy pharmatimes
March 27, 2018
TiGenix and Takeda’s Alofisel has become the first allogeneic stem cell therapy to be approved for use across the European Union.
Research connects stem cell therapy with restoring fertility biospectrumasia
March 21, 2018
The authors are currently enrolling new participants with the goal of following more patients for a longer period.